×
About 7,425 results

ALLMedicine™ Hematocrit Center

Research & Reviews  2,517 results

Characteristics and risk factors for thrombosis in POEMS syndrome: a retrospective eval...
https://doi.org/10.1002/ajh.26422
American Journal of Hematology; Mellors PW, Kourelis T et. al.

Nov 26th, 2021 - Thromboses are prevalent in POEMS syndrome, but few risk factors for POEMS-associated thrombosis have been identified. The objective of this study is to identify novel risk factors for POEMS-associated thrombosis. In this retrospective cohort of 2...

Three water restriction schedules used in rodent behavioral tasks transiently impair gr...
https://doi.org/10.1523/ENEURO.0424-21.2021
ENeuro Vasilev D, Havel D et. al.

Nov 25th, 2021 - Water restriction is commonly used to motivate rodents to perform behavioral tasks; however, its effects on hydration and stress hormone levels are unknown. Here, we report daily body weight and bi-weekly packed red blood cell volume and corticost...

A Study of Auxora in Patients With Acute Pancreatitis and Accompanying SIRS
https://clinicaltrials.gov/ct2/show/NCT04681066

Nov 24th, 2021 - This double blind, randomized, placebo-controlled study will evaluate the efficacy, safety, and tolerability of three different dose levels of Auxora in patients with acute pancreatitis and accompanying SIRS. Approximately 216 patients will be ran...

Cytoreductive treatment in real life: a chart review analysis on 1440 patients with pol...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8607972
Journal of Cancer Research and Clinical Oncology; Crodel CC, Jentsch-Ullrich K et. al.

Nov 23rd, 2021 - Patients with polycythemia vera (PV) show an elevated incidence of thromboembolic complications and decreased survival when compared to age-matched healthy individuals. Hypercellularity as indicated by elevated hematocrit, pathophysiological chang...

Methods of Quantifying Intraoperative Blood Loss in Orthopaedic Trauma Surgery: A Syste...
https://doi.org/10.1097/BOT.0000000000002313
Journal of Orthopaedic Trauma; McKibben NS, Lindsay SE et. al.

Nov 21st, 2021 - To collect and present recently published methods of quantifying blood loss in orthopaedic trauma. A systematic review of English-language literature in PubMed, Cochrane Library, and Scopus databases was conducted according to PRISMA guidelines on...

see more →

Drugs  46 results see all →

Clinicaltrials.gov  157 results

A Study of Auxora in Patients With Acute Pancreatitis and Accompanying SIRS
https://clinicaltrials.gov/ct2/show/NCT04681066

Nov 24th, 2021 - This double blind, randomized, placebo-controlled study will evaluate the efficacy, safety, and tolerability of three different dose levels of Auxora in patients with acute pancreatitis and accompanying SIRS. Approximately 216 patients will be ran...

FAST PV and mGFR™ Technology in Congestive Heart Failure
https://clinicaltrials.gov/ct2/show/NCT03808948

Nov 17th, 2021 - This investigator-initiated, one-armed study is designed to evaluate the safety and function of the FAST PV and mGFR Technology in patients with CHF. Data from the FAST PV and mGFR Technology will not be evaluable by the treating physician, but wi...

Study of Brain and Spinal Cord Tumor Growth and Cyst Development in Patients With Von Hippel Lindau Disease
https://clinicaltrials.gov/ct2/show/NCT00005902

Nov 12th, 2021 - Hemangioblastomas of the cerebellum, brainstem and spinal cord are frequent tumors in patients with von Hippel-Lindau (VHL) disease. Rarely, these lesions also affect the cerebrum. Patients often have multiple lesions, many of which are associated...

Noninvasive Monitor of Vascular Volume Fluid Shifts
https://clinicaltrials.gov/ct2/show/NCT05080881

Nov 5th, 2021 - Blood draw subjects: Participation in this study group may last up to 60 minutes. Participants will begin with a brief medical exam to determine eligibility. This will include a review of any history of cardiovascular disease and of medications. P...

Comparison to Early Detect of the Sepsis
https://clinicaltrials.gov/ct2/show/NCT05107297

Nov 4th, 2021 - There are a relatively large number of conditions where urgent intervention is required in order to secure the best outcome for the patient. Examples include sepsis, myocardial infarction (MI). Clinical diagnosis of some of these conditions is not...

see more →

News  247 results

Case: Older patient with T2D has recurrent flushing
https://www.mdedge.com/internalmedicine/article/248875/geriatrics/case-older-patient-t2d-has-recurrent-flushing
Douglas S. Paauw, MD

Nov 18th, 2021 - A 64 year-old man with type 2 diabetes complains of recurrent flushing for the past 6 months. He has had no other symptoms.

FDA approves new interferon for polycythemia vera
https://www.mdedge.com/hematology-oncology/article/248870/bleeding-disorders/fda-approves-new-interferon-polycythemia-vera
M. Alexander Otto

Nov 18th, 2021 - The Food and Drug Administration on Nov. 12 approved ropeginterferon alfa-2b-njft (Besremi), a monopegylated, long-acting interferon, for adults with polycythemia vera, according to an agency press release.

Pegylated Interferon Wins FDA Approval for Polycythemia Vera
https://www.medpagetoday.com/hematologyoncology/hematology/95675

Nov 15th, 2021 - The FDA granted a first-ever approval of an interferon for the rare blood disorder polycythemia vera (PV), also making ropeginterferon alfa-2b-njft (Besremi) the first approved PV therapy that patients can receive regardless of treatment history. ...

Challenges Remain, But Research Abounds in Polycythemia Vera and Myelofibrosis
https://www.onclive.com/view/challenges-remain-but-research-abounds-in-polycythemia-vera-and-myelofibrosis

Oct 6th, 2021 - David S. Snyder, MD Treatment options for patients with polycythemia vera (PV) and myelofibrosis have remained stagnant within the past few years, but there have been novel agents moving through the pipeline, explained David S. Snyder, MD, adding...

Higher Rates of Respiratory Disorders Retrospectively Identified in Polycythemia Vera
https://www.onclive.com/view/higher-rates-of-respiratory-disorders-retrospectively-identified-in-polycythemia-vera

Sep 9th, 2021 - Estimated 4-year mortality rates were greater than 10% in patients with polycythemia vera and vascular complications led to approximately one-third of these deaths, according to a retrospective analysis of the prospective REVEAL trial (NCT02252159...

see more →

Patient Education  3 results see all →